Genetic variations of the apo E-CI-CII cluster gene in Koreans

Clinical Biochemistry

Volumn 30, Issue 3, 1997, Pages 215-219

  Hong, Seung Ho ^a   Kang, Byung Yong ^a   Oh, Ju Hyung ^a   Kim, Jin Q ^b   Lee, Chung Choo ^a  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

apolipoprotein E CI CII cluster; lipid levels; polymorphism

Indexed keywords

APOLIPOPROTEIN C1; APOLIPOPROTEIN C2; APOLIPOPROTEIN E; CHOLESTEROL; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ALLELE; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CLINICAL TRIAL; COLORIMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; KOREA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

APOLIPOPROTEIN C-I; APOLIPOPROTEIN C-II; APOLIPOPROTEINS C; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA; GENE FREQUENCY; GENOTYPE; HUMANS; KOREA; LIPIDS; LIPOPROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0342762023     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(96)00169-5     Document Type: Article

References (29)

1. Brown MS, Goldstein JL. Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic. J Clin Invest 1983; 72: 743-7.
2. Mahley TW, Innerarity TL. Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta 1983; 737: 197-222.
3. Havel RJ, Shore VG, Shore B, Biou DM. Role of specific glycopeptides of human serum lipoproteins in the activation of lipoprotein lipase. Circ Res 1970; 27: 595-8.
4. LaRosa JC, Levy RI, Herbert R, Lux SE, Fredrickson DS. A specific apoprotein activator for lipoprotein lipase. Biochem Biophys Res Comm 1970; 41: 57-60.
5. Lusis AJ, Heinzmann C, Sparkes RS, et al. Regional mapping of human chromosome 19: Organization of genes for plasma lipid transport (APOC1. -C2. and LDLR) and the genes C3, PEPD, and GPI. Proc Natl Acad Sci USA 1986; 83: 3929-33.
6. Weisgraber KH, Rall SC, Mahley RW. Human apoprotein heterogeneity. Cystein-arginine interchanges in the amino acid sequence of the apoE isoform. J Biol Chem 1981; 265: 9077-83.
7. Weisgraber KH, Innerarity TL, Mahley RW. Abnormal lipoprotein receptor-binding activity of the human apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem 1982; 257: 2518-21.
8. Gregg RE, Ghiselli G, Brewer HB. Apolipoprotein B Bethesda: A new variant of apolipoprotein E associated with type III hyperlipoproteinemia. J Clin Endocrinol 1983; 57: 969-74.
9. Yamamura TA, Yamamoto A, Hiramori K. A new isoform of apolipoprotein E-apoE5-associated with hyperlipidemia and atherosclerosis. Atherosclerosis 1984; 50: 159-72.
10. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1-21.
11. Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man. Nature 1977; 269: 604-7.
12. Cumming AM, Robertson FW. Polymorphism at the apoprotein-E locus in relation to risk of coronary disease. Clin Genet 1984; 25: 310-3.
13. Lenzen HJ, Assmann G, Buchwalsky R, et al. Association of apolipoprotein E polymorphism, low density lipoprotein cholesterol, and coronary artery disease. Clin Chem 1986; 32: 778-81.
14. Klasen EC, Talmud PJ, Havekes L, et al. A common restriction fragment length polymorphism of the human apolipoprotein E gene and its relationship to type III hyperlipidemia. Hum Genet 1987; 75: 244-7.
15. Fojo SS, Law SW, Sprecher DL, Gregg RE, Baggio G, Brewer Jr HB. Analysis of the apo C-II gene in apo C-II-deficient patients. Biochem Biophys Res Commun 1984; 124: 308-13.
16. Humphries SE, Williams L, Myklebost O, et al. Familial apolipoprotein CII deficiency: A preliminary analysis of the gene defect in two independent families. Hum Genet 1984; 67: 151-5.
17. Friedwald WT, Levy RI, Fredrikson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
18. Sambrook J, Fritsch EF, Maniatis T, Molecular cloning, A laboratory manual. 2nd ed. Cold Spring Harbor: Laboratory Press, 1989.
19. Hixon JE, Vernier DT. Restriction isotyping of apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990; 31: 545-8.
20. Nillesen WM, Smeets HJM, van Oost BA. Human apo CI HpaI restriction site polymorphism revealed by the polymerase chain reaction. Nucleic Acids Res 1990; 18: 3428.
21. Zysow BR, Pullinger CR, Kane JP. A polymorphic PstI site in intron 2 of the human apolipoprotein C-II gene detected by polymerase chain reaction. Hum Genet 1992; 89: 361.
22. Hallman DM, Boerwinkle E, Saha N, et al. The apolipoprotein E polymorphisms: A comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991; 49: 338-49.
23. Siest G, Pillot T, Regis-Bailly A, et al. Apolipoprotein R: An important gene and protein to follow in laboratory medicine. Clin Chem 1995; 41: 1068-86.
24. Kamboh MI. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease. Hum Biol 1995; 67: 195-215.
25. Davingnon J, Gregg RE, Sing CF. Apolipoportein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1-21.
26. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J 1987; 113: 433-40.
27. Sepehrnia B, Kamboh MI, Adams-Campell LL, et al. Genetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks. Am J Hum Genet 1989; 45: 586-91.
28. Sandholzer C, Delport R, Vermaak H, Utermann G. High frequency of the apo ε4 allele in Khoi San from South Africa. Hum Genet 1995; 95: 46-8.
29. Korneluk RG, MacLeod HL, Leblond SC, Monteith NL, Baralle FE, Hunter AGW. Avail RFLP at the human apolipoprotein CII (APO CII) gene locus. Nucleic Acids Res 1987; 15: 6769.